Ramucirumab plus FOLFIRI or irinotecan as second-line therapy in advanced or metastatic gastric or gastroesophageal junction adenocarcinoma
@article{JGO47519,
author = {Verena Schlintl and Florian Huemer and Richard Greil and Lukas Weiss},
title = {Ramucirumab plus FOLFIRI or irinotecan as second-line therapy in advanced or metastatic gastric or gastroesophageal junction adenocarcinoma},
journal = {Journal of Gastrointestinal Oncology},
volume = {12},
number = {2},
year = {2020},
keywords = {},
abstract = {},
issn = {2219-679X}, url = {https://jgo.amegroups.org/article/view/47519}
}